Zhang and colleagues demonstrated that leukemia antigen-specific T cell responses and survival following AML induction were significantly superior in PD-1-deficient mice, and also in wildtype mice following administration of anti-PD-L1 blocking antibodies [40]. This evidence concerns the gene PDCD1 and acute myeloid leukemia.